Sabby Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sabby Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14	Closed	-$124K	–	191
2017 Q3	$124K	Sell	14 -136	-91%	-$10.4K	0.01%	139
2017 Q2	$995K	Sell	150 -142	-49%	-$17.6K	0.07%	100
2017 Q1	$6.33M	Buy	+292	New	+$41.7K	0.34%	39
2016 Q4	–	Sell	-11	Closed	-$150K	–	334
2016 Q3	$150K	Sell	11 -7	-39%	-$695	0.01%	280
2016 Q2	$97K	Sell	18 -8	-31%	-$992	0.01%	264
2016 Q1	$420K	Sell	26 -26	-50%	-$5.27K	0.02%	221
2015 Q4	$1.7M	Buy	52 +4	+8%	+$1.3K	0.09%	138
2015 Q3	$1.54M	Sell	48 -107	-69%	-$47K	0.06%	190
2015 Q2	$6.18M	Sell	155 -11	-7%	-$4.67K	0.23%	83
2015 Q1	$8.18M	Buy	+166	New	+$64.3K	0.34%	55
2014 Q3	–	Sell	-18	Closed	-$435K	–	305
2014 Q2	$435K	Hold	18	–	–	0.02%	199
2014 Q1	$472K	Buy	+18	New	+$5.5K	0.03%	181

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's LUMO Position: Q3 2017 in Review

Sabby Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 15,339 shares — an estimated $1.18M sold.

Sabby Management first reported a position in LUMO in Q2 2014 and held it in 8 quarters. The position peaked at $6.23M in Q4 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

Sabby Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Sabby Management sold 15,339 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $1.18M.
Sabby Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Sabby Management's Lumos Pharma, Inc. Common Stock position peaked at $6.23M in Q4 2015.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.